Table 10.
Univariate and multivariate analysis of progression-free survival
| Characteristic | N | Median PFS | Univariate | Multivariate | |
|---|---|---|---|---|---|
| (months) | P value | HR (95 %CI) | P value | ||
| FIGO stage | 0.004 | 1.62 (1.16–2.27) | 0.001 | ||
| IIIC | 305 | 15.3 | |||
| IV | 46 | 11.4 | |||
| Residual disease in upper abdomen | <0.001 | 1.29 (1.16–1.44) | 0.002 | ||
| 0 cm | 75 | 23.3 | |||
| 0–0.5 cm | 54 | 17.8 | |||
| 0.5–1 cm | 85 | 13.5 | |||
| >1 cm | 137 | 12.6 | |||
| Total | 351 | 14.7 | |||
Abbreviations: N number of patients, FIGO International Federation of Gynecology and Obstetrics, PFS progression-free survival, HR hazard ratio, 95 % CI 95 % confidence interval